2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 09:16, 23 November 2023
, 23 November 2023→Potential Benefits
(→Todo) Tags: Mobile edit Mobile web edit |
|||
| Line 127: | Line 127: | ||
* '''Safety''': basically safe under the existing intervention dose and time | * '''Safety''': basically safe under the existing intervention dose and time | ||
* '''Sleep quality''': no significant improvement{{pmid|35215405}} | * '''Sleep quality''': no significant improvement{{pmid|35215405}} | ||
* '''Physical activity''': prevented aging-related muscle dysfunctions and improving physical performance{{pmid|35215405}} | * '''Physical activity''': prevented aging-related muscle dysfunctions and improving physical performance{{pmid|35215405}}{{pmid|35927255}}{{pmid|34238308}}{{pmid|35821806}} | ||
* '''Ear''': improved the right auditory ability of old men{{pmid|35927255}} | * '''Ear''': improved the right auditory ability of old men{{pmid|35927255}} | ||
* '''Cognition''': no significant improvement{{pmid|35927255}} | * '''Cognition''': no significant improvement{{pmid|35927255}} | ||